Log in

OTCMKTS:EMBI - OTCMKTS:EMBI Stock Price, Forecast & News

0.00 (-1.96 %)
(As of 02/27/2020 03:54 AM ET)
Today's Range
Now: $0.09
50-Day Range
MA: $0.14
52-Week Range
Now: $0.09
Volume146,929 shs
Average Volume395,821 shs
Market Capitalization$12.80 million
P/E RatioN/A
Dividend YieldN/A
Emerald Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of bioengineered cannabinoid-based therapeutics for unmet medical needs worldwide. The company's lead product candidate is NB1111 for the treatment of glaucoma. Its products pipeline also comprise NB2222 for the treatment of dry eye syndrome, macular degeneration, and diabetic retinopathy; and NB3000 for the treatment of methicillin-resistant Staphylococcus aureus. The company was formerly known as Nemus Bioscience, Inc. and changed its name to Emerald Bioscience, Inc. in March 2019. Emerald Bioscience, Inc. was founded in 2012 and is headquartered in Long Beach, California.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:EMBI



Sales & Book Value

Annual SalesN/A
Book Value($0.12) per share


Net Income$-19,190,000.00


Market Cap$12.80 million
Next Earnings Date3/12/2020 (Estimated)
OptionableNot Optionable

Receive EMBI News and Ratings via Email

Sign-up to receive the latest news and ratings for EMBI and its competitors with MarketBeat's FREE daily newsletter.

OTCMKTS:EMBI (OTCMKTS:EMBI) Frequently Asked Questions

What is OTCMKTS:EMBI's stock symbol?

OTCMKTS:EMBI trades on the OTCMKTS under the ticker symbol "EMBI."

When is OTCMKTS:EMBI's next earnings date?

OTCMKTS:EMBI is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for OTCMKTS:EMBI.

Has OTCMKTS:EMBI been receiving favorable news coverage?

Headlines about EMBI stock have trended negative recently, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. OTCMKTS:EMBI earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for OTCMKTS:EMBI.

Who are some of OTCMKTS:EMBI's key competitors?

What other stocks do shareholders of OTCMKTS:EMBI own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OTCMKTS:EMBI investors own include Autodesk (ADSK), BioLife Solutions (BLFS), Cognex (CGNX), NeoGenomics (NEO), Proofpoint (PFPT), Elanco Animal Health (ELAN), Palo Alto Networks (PANW), Panasonic (PCRFY), Arena Pharmaceuticals (ARNA) and Amyris (AMRS).

How do I buy shares of OTCMKTS:EMBI?

Shares of EMBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is OTCMKTS:EMBI's stock price today?

One share of EMBI stock can currently be purchased for approximately $0.09.

How big of a company is OTCMKTS:EMBI?

OTCMKTS:EMBI has a market capitalization of $12.80 million. OTCMKTS:EMBI employs 3 workers across the globe.View Additional Information About OTCMKTS:EMBI.

What is OTCMKTS:EMBI's official website?

The official website for OTCMKTS:EMBI is http://www.emeraldbio.life/.

How can I contact OTCMKTS:EMBI?

OTCMKTS:EMBI's mailing address is 130 NORTH MARINA DRIVE, LONG BEACH CA, 90803. The company can be reached via phone at 949-336-3443.

MarketBeat Community Rating for OTCMKTS:EMBI (OTCMKTS EMBI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  9 (Vote Outperform)
Underperform Votes:  8 (Vote Underperform)
Total Votes:  17
MarketBeat's community ratings are surveys of what our community members think about OTCMKTS:EMBI and other stocks. Vote "Outperform" if you believe EMBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EMBI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Featured Article: What is Cost of Debt?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel